- Home
- ALHC vs LIVN Comparison
ALHC vs LIVN Comparison
Compare ALHC & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALHC | LIVN |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALHC | LIVN |
|---|---|---|
| Price | $14.81 | $80.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | $23.13 | ★ $72.43 |
| AVG Volume (30 Days) | ★ 4.3M | 513.5K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | 0.22 | ★ 0.40 |
| Revenue | ★ $3,948,719,000.00 | N/A |
| Revenue This Year | $33.69 | $9.79 |
| Revenue Next Year | $24.74 | $6.63 |
| P/E Ratio | $375.70 | ★ $202.66 |
| Revenue Growth | ★ 46.06 | N/A |
| 52 Week Low | $12.97 | $41.13 |
| 52 Week High | $25.12 | $85.27 |
Technical Indicators
Market Signals| Indicator | ALHC | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 31.27 | 50.87 |
| Support Level | $15.99 | $61.63 |
| Resistance Level | $21.96 | $80.96 |
| Average True Range (ATR) | 1.17 | 2.39 |
| MACD | -0.52 | -0.18 |
| Stochastic Oscillator | 34.76 | 60.77 |
Price Performance
Historical ComparisonAbout ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.